Matthew Beaver

Company: Amgen Inc.

Job title: Director - Process Development

Seminars:

When will the Infrastructure be In Place for Continuous to Overtake Batch? 3:40 pm

• Evaluation of currently available external manufacturing infrastructure for small and large molecules, is this ahead, behind or inline with in-house? • What needs to be overcome for continuous to overtake batch as the preferred method of production cross the industry? • How to adapt continuous equipment suites so they are as flexible as batch…Read more

day: Day Two AM

From Unit Operation Implementation to End-to-End Strategy 4:45 pm

• Strategic and technical evaluation of end-to-end vs hybrid/unit operation approach for small molecule continuous manufacturing • Where does each application bring the most value for the process and business? • Our approach for integrated continuous trains and data from recent projectsRead more

day: Day One AM